6.00% -0.0612

Vaxart Inc (VXRT)

Vaxart Inc (VXRT) 最新ニュース

Vaxart Inc (VXRT)

Vaxart Inc (VXRT) 最新ニュース

Vaxart GAAP EPS of -$0.14 in-line, revenue of $2.18M beats by $1.38M - MSN

Is the Options Market Predicting a Spike in Vaxart (VXRT) Stock? - Yahoo New Zealand News

Vaxart (NASDAQ:VXRT) Share Price Crosses Above Two Hundred Day Moving Average of $0.89 - MarketBeat

Vaxart (NASDAQ:VXRT) Shares Pass Above 200-Day Moving Average of $0.89 - Defense World

Vaxart, Inc. (NASDAQ:VXRT) Q1 2024 Earnings Call Transcript - Insider Monkey

Earnings call: Vaxart posts progress in vaccine trials, Q1 financials - Investing.com

Vaxart earnings missed by $0.02, revenue topped estimates - Investing.com ZA - Investing.com South Africa

Vaxart up 10% on quarterly revenue beat, eyes COVID oral vaccine trial start in Q2 - Seeking Alpha

Vaxart Stock Climbs After Blockbuster Q1 Revenue - Vaxart (NASDAQ:VXRT) - Benzinga

Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results - GlobeNewswire

Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results - Yahoo Finance

All You Need to Know About VAXART, INC. (VXRT) Rating Upgrade to Buy - Yahoo Movies Canada

Vaxart (VXRT) Scheduled to Post Earnings on Monday - MarketBeat

Vaxart (VXRT) to Release Earnings on Monday - MarketBeat

Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13 - Investing.com South Africa

Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13 - Investing.com India

VAXART, INC. (VXRT) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Movies Canada

Vaxart (NASDAQ:VXRT) Stock Price Crosses Below 200-Day Moving Average of $0.88 - MarketBeat

Vaxart (NASDAQ:VXRT) Share Price Passes Below 200 Day Moving Average of $0.88 - Defense World

Do Options Traders Know Something About Vaxart (VXRT) Stock We Don't? - Yahoo News Australia

Vaxart announces results for bivalent norovirus vaccine candidate - TipRanks.com - TipRanks

Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers

Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers - GlobeNewswire

Vaxart (NASDAQ:VXRT) Shares Cross Below 200-Day Moving Average of $0.88 - Defense World

Vaxart, Inc. – Meet the CEO - Vaxart, Inc.

Hedge Fund Beats Vaxart Investor's 'Short-Swing' Profits Suit - Law360

Vaxart to Present at World Vaccine Congress Washington 2024 on April 3

Vaxart to Present at World Vaccine Congress Washington 2024 on April 3 - GlobeNewswire

Vaxart reports inducement grants under Nasdaq listing rule - TipRanks.com - TipRanks

Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Vaxart reports inducement grants under Nasdaq listing rule - TipRanks.com - TipRanks

Vaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call Transcript - Yahoo Finance

Vaxart Provides Business Update and Reports Full Year 2023 Financial Results

Vaxart Inc (VXRT) Reports Full Year 2023 Financial Results - Yahoo Finance

Beat the Market Like Zacks: Walmart, Novo Nordisk, Procter & Gamble in Focus

Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14

Vaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14 - Yahoo Finance

Vaxart appoints Steven Lo as new President and CEO - Investing.com

Vaxart Inc Launches New Equity Plan to Attract Talent - TipRanks.com - TipRanks

VAXART, INC. (VXRT) is a Great Momentum Stock: Should You Buy?

VAXART, INC. (VXRT) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

5 Top-Ranked Stocks That Have More Than Doubled Year to Date

5 Top-Ranked Stocks That Have More Than Doubled Year to Date - Yahoo Finance

Investors in Vaxart (NASDAQ:VXRT) from three years ago are still down 81%, even after 19% gain this past week - Simply Wall St

VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy?

VAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy? - Yahoo Finance

Vaxart Regains Compliance with Nasdaq Listing Standards - TipRanks.com - TipRanks

Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge

Thinking about buying stock in Cano Health, Vaxart, Macy's, Albemarle Corp, or BioXcel Therapeutics? - PR Newswire

Biggest stock movers today: Etsy, Shell, Vaxart, Rocket Lab, and more (NASDAQ:PTON) - Seeking Alpha

VXRTに似た銘柄